Earnings, deals and disclosures from Japan's listed materials & chemicals companies, in English.
Kobe Steel's construction-machinery subsidiary signed a deal to buy 70% of two new CNH-built companies for $700mn on an enterprise-value basis, funded by bridge loans, with closing subject to competition-law approvals and planned for the third quarter of fiscal 2027.
Mitsui Chemicals will buy JSR from JIC Capital funds with DBJ for ¥1.84tn, funded by a ¥1.64tn bridge loan that it says will temporarily lift net debt above four times EBITDA, with closing targeted for the second half of fiscal 2027.
Shinto Paint shareholders vote on 15 January 2027 on a deal giving them 0.0824 Dai Nippon Toryo shares for each Shinto share held, with delisting planned for 22 February and neither company having obtained a fairness opinion from its valuer.
Mitsui Chemicals said it is studying various options to raise corporate value, including the reported JSR acquisition, but that nothing has been decided and the press reports did not come from the company.
Nippon Shokubai closed its ¥20bn purchase of all shares in an Uji-based specialty chemicals maker with resist and insulating-protection materials for semiconductors, and expects only a minor effect on results for the year ending March 2027.
Kansai Paint now owns all of Polisan Kansai Boya after paying $93mn for the other half, and a capital injection to repay the Turkish unit's debt is next; the profit effect is still unquantified.
Sanko Gosei's US unit has signed to buy Cumberland Plastic Systems' Alabama injection-molding business, which had $48.418mn of sales in 2025, with closing scheduled for November 2 at an undisclosed price and a minor expected earnings effect.
Moriroku's board approved selling all equity in its Guangzhou auto-parts subsidiary to a Hong Kong holding company, with transfer planned for mid-December 2026 and the price withheld under a confidentiality clause.
KJ005 now aims to open its Taiyo Holdings tender offer in late November, not early October, with China competition-law and Japan investment-screening procedures still outstanding and Spain and Israel filings no longer needed.
Cluster Technology will issue 996,677 shares at ¥301 to customer Seiko Epson, with payment due October 27, diluting holders by 17.51% and directing most of the ¥296.1mn net to factory works and Epson-lent inspection equipment.
Yodoko paid ¥4.9bn from its own funds for 10.70% of Nakayama Steel Works on October 2, saying the stake supports an alliance to spread high-value electric-furnace steel.
Sekisui Jushi has taken control of Korea's Hi-Q, and its Vietnamese factory subsidiary, for KRW58bn, expecting only a minor effect on current-year forecasts with earnings contribution starting in the quarter to March 2027.
Nippon Chutetsukan will move its straight ductile iron pipe production into a new company and sell 19.9% to Kubota, with the January 4, 2027 start conditional on a December 17 shareholder vote.
Tokuyama expects a ¥30.5bn special gain and a separate ¥12bn impairment loss from selling its domestic cement sales business, and is still working out whether its full-year forecast changes.
Resonac's in-kind distribution of Crasus Chemical shares took effect on 1 October, leaving it with 18.57% of the voting rights and ending the parent relationship, while the effect on consolidated results is still under review.
Both boards voted on 29 September to cancel their February integration memorandum after failing to agree terms, and Kanadevia now expects to publish its next medium-term plan around spring 2027.
Crasus Chemical is now trading in Tokyo, and Resonac expects its October 1 share distribution to leave it with 18.57%, so the petrochemicals unit drops out of both consolidation and equity-method accounting.
Japan's consumer-health group says affiliates of buyout firms NSSK and CVC Capital Partners have made a non-binding joint proposal to take it private, confirming a claim from media reports the company itself never issued.
Sekisui Chemical has agreed to pay about A$335mn for 51% of Brisbane homebuilder Ausbuild, with a later purchase planned to lift its stake to 90%, as it looks to bring its Sekisui Heim factory-built housing method into Ausbuild's townhouse business amid Queensland's chronic housing shortage.
FUJIFILM is selling its Chinese printing-plate subsidiary and ceding sales rights outside Japan, the US, Canada and Mexico to Huangshan Jinruitai Technology, shrinking a unit that made up less than 1% of group revenue while it weighs a broader spin-off of the segment.
Tokyo Stock Exchange approval for Crasus Chemical's listing removes the sole condition on Resonac's planned October 1 split, under which shareholders get one new share for every Resonac share held on September 30 and a ¥303.9bn-revenue petrochemicals business comes off Resonac's consolidated books.
Toyobo is transferring 297,000 square meters of land at its El Salvador unit IUSA, due to close at the end of November 2026, in two tranches through May 2027, booking gains as special items but withholding the sale price by agreement with the buyers.
Hodogaya Chemical closed its takeover of Hungarian API maker Framochem on August 25, giving Japan's original phosgene producer a European manufacturing base for the first time, though the earnings effect for the year to March 2027 is still under review.
Resonac will distribute shares in its petrochemicals subsidiary directly to its own shareholders on a one-for-one basis, a ¥37.8bn book-value dividend that drops its stake below 20% and pulls the unit out of its consolidated results, assuming Tokyo Stock Exchange approves the listing planned for September 29 ahead of the October 1 distribution.